Search research articles
Contact Us
Filters
Showing results (231-240 of 268) with videos related to
Page
of 27
Sort By:
Journal of the International AIDS Society
|
October 8, 2015
Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care
Angela Cescon, Sophie Patterson, Colin Davey, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 25, 2010
A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression
Mona R Loutfy, Miguel Genebat, David Moore, et al.
Canadian Liver Journal
|
February 23, 2026
The 14th Canadian Symposium on Hepatitis C Virus: From research breakthroughs to equitable health care for priority populations
Daniel N Elakpa, David Lawton, Trinity H Tooley, et al.
Gastro Hep Advances
|
May 25, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIV
Felice Cinque, Michael Nudo, Sahar Saeed, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 27, 2021
Routinized Syphilis Screening Among Men Living With Human Immunodeficiency Virus: A Stepped Wedge Cluster Randomized Controlled Trial
Ann N Burchell, Darrell H S Tan, Ramandip Grewal, et al.
BMJ Open
|
December 17, 2021
CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study
Cecilia T Costiniuk, Joel Singer, Marc-André Langlois, et al.
Canadian Liver Journal
|
August 22, 2022
The Z-Profile Study: a multicenter, retrospective cohort study to assess the real-world use and effectiveness of elbasvir/grazoprevir in Canadian adult patients with chronic hepatitis C
Edward Tam, Julie Tremblay, Chris Fraser, et al.
The Lancet. Infectious Diseases
|
May 14, 2021
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial
Timo Vesikari, Joanne M Langley, Nathan Segall, et al.
Vaccine
|
June 29, 2024
COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies
Sita Bhella, Allison M Wilkin, Katrina Hueniken, et al.
Antiviral Therapy
|
December 8, 2016
A comparison of virological suppression and rebound between Indigenous and non-Indigenous persons initiating combination antiretroviral therapy in a multisite cohort of individuals living with HIV in Canada
Anita C Benoit, Jaime Younger, Kerrigan Beaver, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 268) with videos related to
Sort By:
Page
of 27
Journal of the International AIDS Society
|
October 8, 2015
Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care
Angela Cescon, Sophie Patterson, Colin Davey, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 25, 2010
A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression
Mona R Loutfy, Miguel Genebat, David Moore, et al.
Canadian Liver Journal
|
February 23, 2026
The 14th Canadian Symposium on Hepatitis C Virus: From research breakthroughs to equitable health care for priority populations
Daniel N Elakpa, David Lawton, Trinity H Tooley, et al.
Gastro Hep Advances
|
May 25, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIV
Felice Cinque, Michael Nudo, Sahar Saeed, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 27, 2021
Routinized Syphilis Screening Among Men Living With Human Immunodeficiency Virus: A Stepped Wedge Cluster Randomized Controlled Trial
Ann N Burchell, Darrell H S Tan, Ramandip Grewal, et al.
BMJ Open
|
December 17, 2021
CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study
Cecilia T Costiniuk, Joel Singer, Marc-André Langlois, et al.
Canadian Liver Journal
|
August 22, 2022
The Z-Profile Study: a multicenter, retrospective cohort study to assess the real-world use and effectiveness of elbasvir/grazoprevir in Canadian adult patients with chronic hepatitis C
Edward Tam, Julie Tremblay, Chris Fraser, et al.
The Lancet. Infectious Diseases
|
May 14, 2021
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial
Timo Vesikari, Joanne M Langley, Nathan Segall, et al.
Vaccine
|
June 29, 2024
COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies
Sita Bhella, Allison M Wilkin, Katrina Hueniken, et al.
Antiviral Therapy
|
December 8, 2016
A comparison of virological suppression and rebound between Indigenous and non-Indigenous persons initiating combination antiretroviral therapy in a multisite cohort of individuals living with HIV in Canada
Anita C Benoit, Jaime Younger, Kerrigan Beaver, et al.
Page
of 27